[HTML][HTML] Buprenorphine implementation at syringe service programs following waiver of the Ryan Haight Act in the United States
BH Lambdin, RN Bluthenthal, HE Tookes… - Drug and alcohol …, 2022 - Elsevier
Introduction Among people with an opioid use disorder in the United States, only 10%
receive buprenorphine treatment. The Ryan Haight Act is a federal law that has regulated
buprenorphine delivery, requiring an in-person examination between a patient and provider
before initiating treatment. At the beginning of the COVID-19 pandemic, federal agencies
waived in-person examination requirements for buprenorphine treatment initiation. We
examined whether Ryan Haight Act waiver improved implementation of telehealth …
receive buprenorphine treatment. The Ryan Haight Act is a federal law that has regulated
buprenorphine delivery, requiring an in-person examination between a patient and provider
before initiating treatment. At the beginning of the COVID-19 pandemic, federal agencies
waived in-person examination requirements for buprenorphine treatment initiation. We
examined whether Ryan Haight Act waiver improved implementation of telehealth …
以上显示的是最相近的搜索结果。 查看全部搜索结果